title: Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold.
authors.affiliation: Stockport Health Authority, Stockport SK7 5BY. R.Foy@ed.ac.uk
authors.forename: R
authors.initials: R
authors.lastname: Foy
authors.forename: J
authors.initials: J
authors.lastname: So
authors.forename: E
authors.initials: E
authors.lastname: Rous
authors.forename: J H
authors.initials: JH
authors.lastname: Scarffe
mesh_terms: D000553:Ambulatory Care / Q000458:organization & administration; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D002173:Cancer Care Facilities; D016527:Drug Costs; D019317:Evidence-Based Medicine; D005246:Feedback; D006292:Health Priorities; D006760:Hospitalization; D006801:Humans; D008495:Medical Oncology; D017063:Outcome Assessment, Health Care; D006113:United Kingdom